Oral Glucose‐Lowering Agents

Bailey, Clifford J.; Krentz, Andrew J.

doi:10.1002/9781118924853.ch31

Cited by 1 publication

(1 citation statement)

References 90 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The authors see the solution in the improvement of pre-and postgradual education of doctors and other health care providers (nurses, educators, psychologists), in their mutual cooperation and the translation of their knowledge towards a system of successful patient education. A kettes típusú cukorbetegek kezelési lehetőségeiben az utóbbi években jelentős előrehaladás következett be, és az újonnan felfedezett és bevezetett gyógyszerek hatásossága egyértelműen bizonyított [1]. Az is vitathatatlan tény, hogy a diabetes micro-és macrovascularis szövődményei megelőzésének elengedhetetlen feltétele a jó anyagcserekontroll, de sajnos az is igaz, hogy a 2-es típusú cukorbetegek jelentős részében ez a feltétel nem teljesül [2].…”

Section: Barriers Of the Initiation Of Insulin Treatment In Type 2 DIunclassified

Az inzulinkezelés elkezdésének gyakorlati akadályai 2-es típusú cukorbetegekben – a „pszichológiai inzulinrezisztencia” leküzdése

Rácz

Linková²,

Jakubowski³

et al. 2019

Orvosi Hetilap

View full text Add to dashboard Cite

Type 2 diabetes is a progressive disease and its consequence is the gradual decrease of endogenous insulin secretion to a very low level. Beyond this point, without insulin it is not possible to achieve proper metabolic compensation. The authors are trying to explain why the insulin therapy is often delayed in type 2 diabetic patients despite existing guidelines about its initiation and continuation. The causes of delay can be divided into two groups. One is the fear and disagreement of the patients (psychological insulin resistance – PIR) arising from different cognitive, emotional and other reasons. The second is the “clinical inertia”, when the physicians are not able to explain in an effective and persuasive way the rationale and necessity of insulin treatment to their patients. The common background of both causes is the lack of sufficient knowledge about the pathogenesis of type 2 diabetes and the rationale of insulin treatment together with an insufficient level of communication between doctor and patient. The authors see the solution in the improvement of pre- and postgradual education of doctors and other health care providers (nurses, educators, psychologists), in their mutual cooperation and the translation of their knowledge towards a system of successful patient education. Orv Hetil. 2019; 160(3): 93–97.

show abstract

Section: Barriers Of the Initiation Of Insulin Treatment In Type 2 DIunclassified